NICE, the National Institute for Health and Clinical Excellence have changed what they recommend for treating type 2 diabetes under the National Health Service . The new diabetes guidelines include the use of DPP-4 inhibitors.
DPP-4 inhibitors are a class of diabetes drugs that are in wide use. Applied when metformin fails to help control blood sugar levels, the drugs are used as a second-line therapy amongst those who face a strong risk of hypoglycaemia or cannot take metformin.
The NICE advises people with type 2 diabetes to focus on a healthy lifestyle, blood pressure and lipid levels controls, and lowering the amount of blood glucose . Professor Anthony Barnett was reported as commenting: “One of the key issues when considering treatment options is striking a balance of achieving optimal glycaemic control while also minimising the risk of hypoglycaemia.”

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…